Research Projects & Trials
- Systemic and cardiac complications of seizures and status epilepticus in the Epilepsy Monitoring Unit and the NeuroICU.
- Using quantitative EEG markers and physiologic measurements to predict neurologic outcomes after cardiac arrest.
- Analysis of multiple physiologic data to predict vasospasm in subarachnoid hemorrhage.
- Established Epilepticus Treatment Trial (ESETT): determining the second-line drug therapy for status epilepticus.
- Rotational Thromboelastometry for Monitoring the Effect of Prothrombin Complex Concentrate for Coagulopathy Reversal in Patients with Warfarin-Associated Intracerebral Hemorrhage.
- Riluzole in Spinal Cord Injury Study (RISCIS): A Multi-Center, Randomized, Placebo Controlled, Double-Blinded, Trial of Efficacy and Safety of Riluzole in Acute Spinal Cord Injury
- Inmate inflammation in Subarachnoid hemorrhage (SAH).
- The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal ScaffoldTM for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury
- MISTIE-III: A phase III, randomized, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage.
- The DECS Trial: Dexamethasone Versus Burr Hole Craniostomy for Symptomatic Chronic Subdural Hematoma.
- SHINE Trial: The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial is a multicenter, randomized, controlled clinical trial of 1400 patients that will include approximately 60 enrolling sites. The study hypotheses are that treatment of hyperglycemic acute ischemic stroke patients with targeted glucose concentration (80mg/dL – 130 mg/dL) will be safe and result in improved 3 month outcome after stroke.
For a full list of clinical trials at UVA, please visit the following website: https://uvahealth.com/clinicaltrials